Editorial: COVID-19 vaccines are safe and effective in patients with inflammatory bowel disease-but many unanswered questions remain.

Aliment Pharmacol Ther

SickKids Inflammatory Bowel Disease Centre, Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, Toronto, Canada.

Published: July 2022

AI Article Synopsis

  • This article references the research conducted by Bhurwal et al.
  • It includes links to two specific scholarly papers for further reading.
  • The provided URLs lead to detailed studies published in "Alimentary Pharmacology & Therapeutics."

Article Abstract

This article is linked to Bhurwal et al papers. To view these articles, visit https://doi.org/10.1111/apt.16913 and https://doi.org/10.1111/apt.16935

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349439PMC
http://dx.doi.org/10.1111/apt.16935DOI Listing

Publication Analysis

Top Keywords

editorial covid-19
4
covid-19 vaccines
4
vaccines safe
4
safe effective
4
effective patients
4
patients inflammatory
4
inflammatory bowel
4
bowel disease-but
4
disease-but unanswered
4
unanswered questions
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!